精氨酸酶(ARG)多克隆抗體
Polyclonal Antibody to Arginase (ARG)
ARG1; Arginase I; Liver Arginase
- 編號UPAB120Rb51
- 物種Oryctolagus cuniculus (Rabbit，兔) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主豚鼠
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物別藻藍蛋白
- 免疫原 RPB120Rb01-精氨酸酶(ARG)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度0.5mg/mL
- 且適物種Homo sapiens (Human，人)
- 應用IHC; ICC/IF
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 326 ¥ 760 ¥ 1086 ¥ 2715 ¥ 10860
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
DAB staining on IHC-P; Sample: Rabbit Liver Tissue; Primary Ab: 20μg/ml Cavia Anti-Rabbit Arg Antibody Second Ab: 2μg/mL?HRP-Linked Rabbit Anti-Cavia IgG Polyclonal Antibody (Catalog: SAA544Gu09)
-
DAB staining on IHC-P;
Sample: Rabbit Kidney Tissue;
Primary Ab: 20μg/ml Cavia Anti-Rabbit Arg Antibody
Second Ab: 2μg/mL?HRP-Linked Rabbit Anti-Cavia IgG Polyclonal Antibody
(Catalog: SAA544Gu09) -
AF488 staining on IF;
Sample: HepG2 cell
Primary Ab: 20μg/ml Cavia Anti-Rabbit Arg Antibody
Second Ab: 2μg/ml AF488-Linked Rabbit Anti-Cavia IgG Polyclonal Antibody
(Catalog: SAA544Gu01)
-
Figure. Western Blot; Sample: Recombinant ARG, Rabbit.
-
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對ARG的豚鼠多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別ARG。
用法
Immunohistochemistry: 5-20μg/mL;
Immunofluorescence: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Oryctolagus cuniculus (Rabbit，兔) | 應用(僅供研究使用，不用于臨床診斷！) |
| URPB120Rb01 | 精氨酸酶(ARG)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAB120Rb51 | 精氨酸酶(ARG)多克隆抗體 | IHC; ICC/IF |
| ULAB120Rb71 | 精氨酸酶(ARG)多克隆抗體(生物素標記) | IHC |
參考文獻
| 雜志 | 參考文獻 |
| PLoS One | Phenobarbital Induces Alterations in the Proteome of Hepatocytes and Mesenchymal Cells of Rat Livers [Pubmed: 24204595] |
| J Cereb Blood Flow Metab | Arginase I release from activated neutrophils induces peripheral immunosuppression in a murine model of stroke [PubMed: 25966956] |
| Cancer Medicine | Circulating CD14+HLA-DR-/low myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease [Pubmed:27109254] |
| Cell Mol Immunol? | Toxoplasma gondii GRA15II effector-induced M1 cells ameliorate liver fibrosis in mice infected with Schistosomiasis japonica [Pubmed:27157496] |
| Potent but transient immunosuppression of T-cells is a general feature of erythroid progenitor cells [] | |
| Commun Biol | Potent but transient immunosuppression of T-cells is a general feature of CD71+ erythroid cells [34893694] |
留言咨詢
